Michael P Dube (VP, Chief Accounting Officer) sold ~$23K of Intellia Therapeutics
Automatic saleLoading…
Insider tradesView the official recordSEC Form 144 — Notice of Proposed Sale of Securities
Planned sale
Officer filed to sell about $736K of NTLA stock
Planned for Oct 5, 2026 · Notice filed Oct 5, 2026
- ~$736K
- planned to sell · 58K shares, around Oct 5, 2026
Why it stands out
A Intellia Therapeutics officer told the SEC about a plan to sell $736K of Intellia Therapeutics shares around Oct 5, 2026. The filing says the shares were acquired as compensation. That is a tiny part of all Intellia Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Planned sale date
- Oct 5, 2026
- Reporting period
- Not applicable
- Notice filed with the SEC
- Oct 5, 2026
OfficerPlanned saleShares from pay
Context
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001950047-26-010054
- Filed / recorded
- Oct 6, 2026, 12:45 AM UTC